Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of digital enterprise platforms for cell and gene therapy supply chains, are partnering to produce a fully pre-integrated solution to modernize, fast-track, and streamline the manufacture and delivery of cell and gene therapies (CGTs).
Advanced therapies, such as cell therapies, gene therapies, and personalized cancer vaccines, require infrastructure as advanced as their science. However, systems to manage the production of cell and gene therapies are outdated and often manual. This can severely hamper data clarity, scale, speed, and patient safety. The CGT industry now requires a new level of visibility, detail, and access across each product and facility within the supply chain.